• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Study on adenovirua vector-mediated gene therapy as a therapeuticc approach for bone diseases

Research Project

Project/Area Number 09307032
Research Category

Grant-in-Aid for Scientific Research (A).

Allocation TypeSingle-year Grants
Section一般
Research Field Orthopaedic surgery
Research InstitutionThe University of Tokyo

Principal Investigator

TANAKA Sakae  Univ.y of Tokyo, Faculty of Medicin Aaaistant Prof., 医学部・附属病院, 助手 (50282661)

Co-Investigator(Kenkyū-buntansha) ODA Hiromi  Univ. of Tokyo Faculty of Medicine Associate Prof., 医学部・附属病院, 助教授 (60101698)
NAKAMURA Kozo  Univ. of Tokyo Faculty of Medicine Professor, 医学部・附属病院, 教授 (60126133)
Project Period (FY) 1997 – 2000
KeywordsAdenovirus vector / Osteoclast / csk
Research Abstract

Osteoclasts are primary cells responsible for bone resorption, and the cells play important roles in pathological bone resorption such as osteoporosis, rheumatoid arthritis and metastatic bone tumors as well as normal bone modeling and remodeling. Therefore, revealing the molecular mechanism of osteoclastic bone resorption leads us to establish a novel therapeutic approaches for these disorders. To investigate the function of a molecule in the cells, gene transduction is widely utilized and quite useful. However, because osteoclasts are terminally differentiated non proliferating cells, gene transduction into osteoclasts are extremely difficult. In this project, we demonstrated that adenovirus vectors can efficiently transduce osteoclasts (Tanaka et al., 1998).
The study on the knock-out mice revealed that a non-receptor-type tyrosine kinase, c-Src plays an essential role for osteoclastic bone resorption. We constructed an adenovirus vector carrying csk gene (csk virus), which negatively regulate c-Src activity. Csk virus can efficiently transduce csk gene into osteoclasts, and strongly suppressed bone-resorbing activity of the cells. We further examined the effect of the virus in vivo. Injection of csk virus on the periosteum of mouse calvaria significantly inhibited the bone resorption induced by IL-1 administration. Intraarticular injection of the virus also reduced the bone destruction in adjuvant arthritis rats. These results showed that csk virus can be a good therapeutic means of pathological bone destruction. We will be able to elucidate the molecular mechanism of osteoclastic bone resorption using the method we established.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Yoshida Y.,Tanaka S. et al.: "Segregation of TRAF6 mediated signaling pathways clarifies its role in osteoclastogenesis."EMBO J.. (in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kobayashi N.,Tanaka S. et al.: "Negative regulation of BMP/Smad signaling by Tob in osteoblasts."Cell. 103. 1085-1097 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakagawa T.,Tanaka S. et al.: "Overexpression of the csk gene suppresses tumor metastasis in vivo."Int.J.Cancer. 88. 384-391 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miura T.,Tanaka S. et al.: "Partial functional recovery of paraplegic rat by adenovirus-mediated gene delivery of constitutively active MEK1."Exp.Neurol.. 166. 115-126 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyazaki T.,Tanaka S. et al.: "Reciprocal Role of ERK and NF-κB pathways in survival and activation of osteoclasts."J.Cell Biol.. 148. 333-342 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takayanagi H.,Tanaka S. et al.: "Receptor activator of nuclear factor κB ligand/Osteoclast differentiation factor is involved in osteoclastogenesis from synoviocytes in rheumatoid arthritis."Arthritis Rheum.. 43. 259-269 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] N.Kobayashi, Y.Kadono, A.Naito, K.Matsumoto, T.Yamamoto, S.Tanaka, and J.-I.Inoue.: "Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis."EMBO J. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Yoshida, S.Tanaka, H.Umemori, O.Minowa, M.Usui, N.Ikematsu, E.Hosoda, T.Imamura, J.Kuno, T.Yamashita, K.Miyazono, M.Noda, T.Noda, and T.Yamamoto.: "Negative regulation of BMP/Smad signaling by Tob in osteoblasts."Cell. 103. 1085-1097 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Nakagawa, S.Tanaka, H.Suzuki, H.Takayanagi, T.Miyazaki, K.Nakamura, and T.Tsuruo: "Overexpression of the csk gene suppresses tumor metastasis in vivo."Int.J.Cancer. 88. 384-391 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Miura, S.Tanaka, A.Seichi, M.Arai, T.Goto, H.Katagiri, T.Asano, H.Oda, and K.Nakamura: "Partial functional recovery of paraplegic rat by adenovirus-mediated gene delivery of constitutively active MEK1."Exp.Neurol.. 166. 115-126 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Miyazaki, H.Katagiri, Y.Kanegae, H.Takayanagi, Y.Sawada, A.Yamamoto, M.P.Pando, T.Asano, I.M.Verma, H.Oda, K.Nakamura, and S.Tanaka: "Reciprocal Role of ERK and NF-{kappa} B pathways in survival and activation of osteoclasts."J.Cell Biol.. 148. 333-342 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.Takayanagi, H.Iizuka, T.Juji, T.Nakagawa, A.Yamamoto, T.Miyazaki, Y.Koshihara, H.Oda, K.Nakamura, and S.Tanaka: "Receptor activator of nuclear factor kB ligand/ Osteoclast differentiation factor is involved in osteoclastogenesis from synoviocytes in rheumatoid arthritis."Arthritis Rheum.. 43. 259-269 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi